补肾益智方加减联合常规西药治疗阿尔茨海默病临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R749.16

基金项目:


Clinical Study on Bushen Yizhi Prescription Combined with Routine Western Medicine for Alzheimer Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察补肾益智方加减联合常规西药治疗阿尔茨海默病(AD) 的疗效及对认知功能的影响。 方法:选取62 例AD 患者,按随机数字表法分为对照组和观察组各31 例。对照组给予常规西药治疗,观察组 在对照组基础上给予补肾益智方加减治疗。评价2 组临床疗效,比较2 组治疗前后认知功能、日常生活能力及 氧化应激水平,统计不良反应发生率。结果:观察组总有效率为90.32%,高于对照组67.74%(P<0.05)。治 疗后,2 组简易智力精神状态量表(MMSE)、日常生活能力量表(ADL) 评分高于治疗前,阿尔茨海默病评 定量表认知分量表(ADAS-cog) 评分低于治疗前(P<0.05);且观察组MMSE、ADL 评分高于对照组, ADAS-cog 评分低于对照组(P<0.05)。2 组治疗后超氧化物歧化酶(SOD)、谷胱甘肽二氧化物酶(GSH-Px) 水平高于治疗前,丙二醛(MDA) 水平低于治疗前(P<0.05);观察组治疗后SOD、GSH-Px 水平高于对照 组,MDA 水平低于对照组(P<0.05)。观察组不良反应发生率为6.45%,低于对照组25.81%(P<0.05)。结 论:补肾益智方加减联合常规西药有利于提高AD 患者临床疗效,改善患者痴呆程度及氧化应激反应,提高认 知功能及生活自理能力,降低不良反应发生率。

    Abstract:

    Abstract:Objective:To observe the curative effect of Bushen Yizhi Prescription combined with routine western medicine for Alzheimer disease (AD) and its effect on cognitive function. Methods : A total of 62 cases of AD patients were selected and divided into the control group and the observation group according to the random number table method,with 31 cases in each group. The control group was treated with routine western medicine, and the observation group was additionally treated with Bushen Yizhi Prescription based on the treatment of the control group. The clinical effects in the two groups were evaluated. Before and after treatment, the levels of cognitive function, activities of daily living and oxidative stress in the two groups were compared. The incidence of adverse reactions was observed. Results:The total effective rate was 90.32% in the observation group,higher than that of 67.74% in the control group (P<0.05). After treatment, the scores of Mini- Mental State Examination (MMSE) and Activities of Daily Living (ADL) were higher than those before treatment, and the scores of Alzheimer Disease Assessment Scale-Cognitive (ADAS-Cog) were lower than those before treatment (P<0.05);the scores of MMSE and ADL in the observation group were higher than those in the control group,and the score of ADAS- cog was lower than that in the control group (P<0.05). After treatment, the levels of superoxide dismutase (SOD) and glutathione peroxidase (GSH- Px) in the two groups were higher than those before treatment,and the levels of malondialdehyde (MDA) were lower than those before treatment (P<0.05);the levels of SOD and GSH- Px in the observation group were higher than those in the control group, and the MDA level was lower than that in the control group (P<0.05). The incidence of adverse reactions was 6.45% in the observation group,lower than that of 25.81% in the control group (P<0.05). Conclusion:The therapy of modified Bushen Yizhi Prescription combined with routine western medicine for AD patients is beneficial to improve the clinical effect, dementia degree, oxidative stress reaction, cognitive function and self-care ability,and reduce the incidence of adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

朱敬滨,陈凌.补肾益智方加减联合常规西药治疗阿尔茨海默病临床研究[J].新中医,2023,55(5):95-98

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-03-15
  • 出版日期:
文章二维码